Barclays PLC Q2 2026 Results Fixed Income Conference Call Q&A Transcript (Amended in places to improve accuracy and readability) Lee Street, Citi I have three questions, please. Firstly, just looking at your business mix, you obviously allocate most capital to the investment bank that make high returns in the other divisions. So, my question is, would it make sense to look for further sort of inorganic growth opportunities in the high returning business models to grow those further? That would be my first question. Secondly, on the Bank of England proposals in the Financial Stability Report, what would it take for you to think about changing your management buffer and potentially bring that lower given the idea of releasable buffers? And then finally, you mentioned the international alignment of capital requirements and talking to [the Bank of England] about that. In your view for Barclays, where do you think the biggest gaps are where Barclays [is] most disadvantaged from your perspective? Anna Cross, Group Finance Director In terms of the balance of capital across the group and the relative returns, as you can see, we've been really focused on improving the IB returns, also [with] capital and cost discipline. And we're happy with the structural improvement in returns, and we're not done yet. So, we expect those to continue to edge upwards. On the sort of second part of your question, which is really around, should we pursue inorganic growth elsewhere? We feel like we are pursuing the right pace of organic growth. We've deployed £25 billion of the around £30 billion that we expect to do [between 2024- 2026] in RWAs so far in the UK businesses. And we're growing [lending] at around 5% a year, and we think that's the right rate of growth for organic growth underpinned by the capabilities that we're putting down across both retail and corporate banking. When it comes to inorganic opportunities, the bar is very high for us, so we would want something that would deliver either additional capability or additional volumes. So, Kensington, for example, was capability. Tesco is about volume. When we look at the returns… on any acquisition, we would be considering that relative to the returns on the buyback. So, we're very focused on the capital hierarchy that we have, which is one, regulatory compliance at all times, number two, distributions, [and number three], investment in the business. So that, again, would be a high bar. And then thirdly, we would look at the type of business model that we saw in front of us. And specifically, you'll have seen that we are very much leaning towards digital opportunities. all those with a digital basis to them because we feel those business models have the greatest longevity. So of course, we will continue to look at inorganic opportunities but it's an organic plan. So, expect us to keep plugging away around 5% [lending CAGR] a year. And then to sort of hub tuck-ins as and when we see all those factors being satisfied. In terms of your second question, we've been fairly clear that you should expect us to operate around the top end of our range until we get regulatory clarity, and we expect to get that in two chunks. -- 1 of 8 -- The first, Pillar 2A clarity around Basel 3.1 implementation, which we should receive at some point at the back end of this year. And then secondly, we would expect to get a bit more Pillar 2A clarity when we land our A-IRB model for US cards, which we would expect to be in the second half of next year. Those are the points at which we would reexamine the range within which we operate. Obviously, it's one input, and we would be considering other factors at the same time. Dan Fairclough, Group Treasurer Just to add a little bit on that second question. I mean there's nothing in the FSR proposals that would change the way that we think about offering Barclays. So, the things that Anna referred to are obviously mechanical reductions in the MDA requirements. Obviously, we'll watch as it unfolds on the concept of a single usable buffer, but that feels like that's got quite a long way to run. And obviously, [it] will be a long international discussion. Third question I think you asked was… how do we think about international competitiveness? So, this is an important point for us in terms of our regulatory engagement. There were some positives that came out of the PRA Basel package on [Market Risk] IMA. We felt that they have listened to the industry in a number of areas. And then there are a number of helpful points, particularly around simplification. But more broadly, we think that there is more to be done here, both to promote growth, but also to make sure that there's a level playing field. A couple of things that we would call out is the approach to models broadly, a specification around the US models and the rest of the Basel package, the standardised Basel package more broadly, where we feel there's more to be done. Daniel David, Autonomous I've got three questions. The first two are kind of related. On the leverage changes, which were more targeted at the OSIIs, did you feel a bit harshly treated as a GSIB? I guess did you expect any changes to allow UK GSIBs to become more competitive in the global context. I guess when I look at what's changed, it's mainly OSIIs, as I say. And then I guess related to that, as QT progresses, are you seeing any notable impact on your balance sheet and just what you can extend to certain businesses as leverage maybe becomes a little bit more binding as Central Bank reserves dissipate? Then the final one, Dan, you just mentioned that FPC vision of a single releasable buffer. I guess what stands out in that is that Pillar 2G could become part of the MDA? Do you think that's where we're headed longer term? And interested to hear your views. And then just finally, all the best in the new role Dan. Thank you. Dan Fairclough, Group Treasurer The leverage proposals were obviously a little bit disappointing in terms of the aggregate impact. I don't think it was specifically around the OSII point. Obviously, the Bank of England was using the flexibility that they have within the Basel remit, and one of those was obviously on the CCyB. So really, the reason why some banks got more benefit than others was because the CCyB where the UK obviously is the largest component, was a bigger portion of their capital stack. So, I think it was more -- 2 of 8 -- about what room for manoeuvre did they feel that they had rather than necessarily targeted at OSIIs versus GSIBs specifically. Obviously, there's more to come from the Bank of England overall on this reform package. The second question on QT is interesting. So, we haven't really noticed any particular change in the way that we manage the balance sheet. But it's obviously interesting that we do seem to be moving closer to the preferred minimum reserve level that the Bank of England have cited I think another interesting observation for the market, is just the fact that we are seeing a significant uptick in the use of the Bank of England repo reserve scheme. So that does suggest that other banks in particular are positioning around those reserves scarcities but not impacting us particularly directly. And then your final question, I think it's hard to say where this is going to go because I think the debate is really at the beginning. Clearly, the financial stability report, again, put out a signal that it's a topic that the Bank of England wants to explore, but we still haven't seen any detail on it. So, I expect we will get more of that as we move into both on the Bank of England and then potentially internationally. Robert Smalley, MacKay Shields Thanks very much for doing the call. First, in terms of the IB, the performance and the balance sheet growth, we've seen your domestic competitors really grow their balance sheets and grow a number of different businesses over the past 6 to 12 months. At the same time, you've said that you're going to keep the capital commitment and IB balance sheet pretty much stable. So do you anticipate a growing gap between you and some of your global competitors here as a result of just the size of the businesses going forward? And is your relative muted issuance versus some of, say, the large U.S. banks who need to fund a growing IB balance sheet indicative of this as well? Secondly, you mentioned on the other call earlier this morning, the IPO business was mentioned [with regards to] your participation in it. At the same time, you're also looking to grow your wealth management business. One of the American banks had given some data around employees of IPO’ed companies becoming wealth management clients at their bank. Do you have any data or at least some colour around conversions from where you participated in IPOs and getting those people into the Barclays Wealth Management platform? And then third, just on domestic deposits. I know there's been discussion around this already. But there is a lot of competition. You've done a good job in increasing deposits overall. But where does that go from here? And will you need to issue more out of the OpCo in the institutional market. Anna Cross, Group Finance Director On the U.S. banks, our strategy is well set out here, and it's one of discipline. And what we mean by that is not only running the business for returns but with a risk posture that's appropriate for the environment. And so that's really what you see us doing here. We're extending a bit of balance sheet, both in terms of RWA, more significantly in leverage but we're doing so as a means to an end to ensure that we're getting a commensurate increase in revenue over RWAs, which you can see in the quarter, but also that we manage the risk well. -- 3 of 8 -- So, you'll note the VAR has not really changed, no trading loss days in the quarter. That's really important to us that we manage this business within disciplined boundaries. We feel like we are making good progress. So, we're happy with its structural progress in terms of the consistency of that revenue over RWAs and the consistency of its costs. So, we wouldn't recognize that we feel like we're falling behind our expectations at all. And from here, we do think that there are more opportunities both to optimize within the capital framework that we've given it, but also that much of the growth areas that we're very focused on within this business do not require balance sheet. So, M&A, ECM, the financing business, which is certainly leverage heavy, but not RWA- heavy, and most importantly, the International Corporate Bank. And the other good part of that is, clearly, they are businesses which are more recurring, more fee-based and really address something that Lee was pointing to in his initial question, which is about the lower than group ROTE in that part of the business. To your second question, we actually believe that our wealth opportunity is much wider than that. But just to remind you that our wealth business is a UK focused business. And so there may be somewhat of a geographical gap between where we do our IPO activity and where we do our wealth activity. Clearly, our Private Bank is more of an international factor, but the wealth opportunity is very much UK based and we're really focused on the 400,000 clients that we have in [Barclays] Premier that we believe would benefit from that advice. So, think of it as probably a bit of a narrower geographical focus, Rob, but one that is much wider in terms of the pool of clients that we're going after. Dan Fairclough, Group Treasurer So, UK deposits, obviously, that primarily relates to our ring-fenced bank in the UK. That entity has a very comfortable funding position. But if we felt we needed to do more funding, we would likely do that in secured form and covered. So, very unlikely that we would do any unsecured issuance from the UK [ringfenced bank]. Clearly, we have issued, as I said in the prepared remarks, at the OpCo level for Barclays Bank PLC, which is a non-ringfenced bank, but that's just one of a broad range of funding sources that we have available. Obviously, we raise international deposits there. And we have other wholesale funding instruments across the markets. Violetta Baraboi, Société Générale Just one question actually around funding. 2027 has been mentioned around prefunding. And I would like to understand a little bit more of how I should be thinking about the quantum of that prefunding and within that, what part of the capital structure? So, are we talking more about senior HoldCo issuances to prefund your upcoming dollar maturities early January? Or are you thinking about a little bit of sub debt? And then also a question on the AT1. You issued, obviously, the Australian Dollar. I was trying to understand whether this is a sort of a one-off transaction? Or are you really thinking about being more present in the market going forward? -- 4 of 8 -- Dan Fairclough, Group Treasurer We generally don't give specific guidance on prefunding, and we don't have a fully formed view on what prefunding we would do. So, we will really respond there to market conditions and where we see relative value. So, not too much further to add on that at this point. In terms of the AT1, and obviously, when we come to market, we will look at the broad set of opportunities available to us. Obviously, we have historically focused predominantly on Dollars and Sterling. That's where the market is deepest for us. but we will continue to look at opportunities elsewhere where they're attractive, they provide diversification, and where the pricing is right. So, we've issued in Singapore Dollar as well in the past. We'll be opportunistic in where we go in addition to Dollars and Sterling. Pranjal Vaish, Credit Agricole I saw that your LCR declined from 170% to around 158% at the end of this quarter. compared to the end of last year. Can you please walk us through the key drivers behind this decline, perhaps if you're anticipating any material outflows in the near term? And also if you can share your target operating range for the LCR, if you share that? And the second question would be on the SRTs. I noticed that you had around £700 million benefit this quarter. If you can provide any forward guidance on your SRT pipeline, specifically how much RWA reduction or in terms of CET1 benefit you plan to achieve through SRTs in the coming months or in FY26? Dan Fairclough, Group Treasurer The LCR has declined over the past 12 months or so. This firstly relates to something that we called out probably 12 months ago now, which was a change of methodology within our prime financing business, which moved to a more conservative approach. We report the LCR on a 12-month rolling basis. So that has just taken time to come through the ratio. That was the mechanical effects that we disclosed 12 months ago. And obviously, it's been quite an active quarter in terms of Investment Bank activity and financing, in particular. So we've obviously leaned into that and use some of our funding to support those clients but I wouldn't call anything else out, particularly in terms of where the LCR ratio will go from here. On SRT, we've talked about the broad scope of our SRT activity in the past. The vast majority of our SRT is in the Colonnade program, which provides protection on our corporate loans, that program is largely scaled. I wouldn't call out material changes in that from a volume perspective. And then the rest of the activity that we have is relatively small. Some mortgages and some consumer loans. So, I wouldn't call out too much in terms of the forward pipeline. Largely, that will be replacing the transactions as they come up for amortization. I would say that we have issued a little bit more in the last quarter. We've just stepped into some of the upcoming amortization that we would have from those programs. It's very consistent with what we've done on the overall MREL issuance. We've just got ahead of refinancings. -- 5 of 8 -- Anna Cross, Group Finance Director The only thing I would add to that is just certainly on the BUK side, and I think that's the transaction that you are referring to. There, what you've seen us do is a series of transactions that really allow us to optimize the balance sheet and what we're retaining. And they are one-by-one commercial decisions that we make. And I contrast that as Dan says, with the programmatic nature of Colonnade which is largely at scale. Thank you for those questions. So, I'd just like to thank you all for your interest in Barclays and for joining us on the call today. And whilst he really doesn't want me to do this, I'm going to say thank you to Dan for his 25 years in Barclays. For those of you who don't know, Dan is moving to Australia with his family. So Violetta, you may not see Barclays presence in the Aussie market, but you're definitely going to see Dan down under! And I think you'll all join me in thanking him for his stewardship and wishing him luck on the other side of the world. I suspect this is not the last time we will see Dan Fairclough. -- 6 of 8 -- Important Notice The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information, statements and opinions contained in this presentation do not constitute a public offer under any applicable legislation, an offer to sell or solicitation of any offer to buy any securities or financial instruments, or any advice or recommendation with respect to such securities or other financial instruments. Information relating to: • regulatory capital, leverage, liquidity, resolution and related regimes is based on Barclays' interpretation of applicable rules and regulations as in force and implemented in the UK as at the reporting date, including, but not limited to: CRR; the PRA Rulebook; and any applicable delegated acts, implementing acts or technical standards; in each case as amended and, where applicable, as such rules and regulations form part of domestic law by virtue of the European Union (Withdrawal) Act 2018. All such regulatory requirements are subject to change and disclosures made by the Group will be subject to any resulting changes. The Pillar 2A requirement is also subject to at least annual review; • MREL reported as at 31 December 2025 is based on Barclays' understanding of the Bank of England’s statement of policy on "The Bank of England's approach to setting a minimum requirement for own funds and eligible liabilities (MREL)" published in December 2021, and its MREL requirements communicated to Barclays by the Bank of England. In July 2025, the Bank of England published amendments to the December 2021 MREL statement of policy, which took effect on 1 January 2026. Binding future MREL requirements remain subject to change, as determined by the Bank of England, taking into account a number of factors as described in the amended statement of policy, along with international developments; • future regulatory capital, leverage, liquidity, funding and/or MREL, including forward-looking illustrations, are provided for illustrative purposes only and are not forecasts of Barclays’ results of operations or capital position or otherwise. Illustrations regarding the capital flight path, end-state capital evolution and expectations and MREL build are based on certain assumptions applicable at the date of publication only which cannot be assured and are subject to change. Non-IFRS performance measures Barclays’ management believes that the non IFRS performance measures included in this presentation provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this presentation are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix of the Barclays PLC Results Announcements for each of the periods ended 30 June 2021, 30 June 2023, 30 June 2025, 30 September 2025, 31 December 2025, 31 March 2026 and 30 June 2026, and the Group Reporting Changes 2023 Results Resegmentation Document, respectively, which are available at Barclays.com, for further information and calculations of non-IFRS performance measures included throughout this presentation, and the most directly comparable IFRS measures. Forward-looking statements This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward- looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. -- 7 of 8 -- Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including sustainability-related commitments and targets), plans and objectives for future operations, International Financial Reporting Standards (“IFRS”) and other statements that are not historical or current facts. By their nature, forward- looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); changes in tax laws and practice; the outcome of current and future legal proceedings and regulatory investigations; the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in which climate policy is implemented in the regions where the Group operates, including as a result of the adoption of rules and regulations taking a different or opposing position on sustainability matters, or other forms of governmental and regulatory action against sustainability policies; environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; financial crime; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences of the conflicts in the Middle East and Ukraine on European and global macroeconomic conditions, political stability and financial markets; changes in US legislation and policy; developments in the UK’s relationship with the European Union; the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Group’s reputation, business or operations; the use of new technology, including artificial intelligence; the Group’s ability to access funding; and the success of acquisitions, disposals, joint ventures and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. In setting its targets and outlook for the period 2026-2028, Barclays has made certain assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the US Securities and Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2025), which are available on the SEC’s website at www.sec.gov. Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise. -- 8 of 8 --